Related Experiment Video
Updated: Mar 12, 2026

07:27
High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs
Published on: August 3, 2011
21.2K
TaqMan Low Density Array: MicroRNA Profiling for Biomarker and Oncosuppressor Discovery
1School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland. obrienk9@tcd.ie.
Methods in Molecular Biology (Clifton, N.J.)
|November 10, 2016
Summary
Researchers explored microRNAs (miRNAs) as potential biomarkers and therapeutics. They developed a method to identify and test miRNAs from cell lines and clinical samples for disease diagnosis and treatment via miRNA restoration.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are increasingly recognized for their roles as biomarkers and biotherapeutics.
- The discovery of circulating miRNAs in 2008, coupled with high-throughput profiling, spurred research into their diagnostic potential.
- miRNAs regulate cellular processes, making them targets for therapeutic intervention through restoration.
Purpose of the Study:
- To present a comprehensive approach for discovering microRNAs with biomarker and therapeutic potential.
- To detail methods for isolating, profiling, and validating miRNAs from various sources.
- To examine the therapeutic efficacy of miRNA restoration in vitro.
Main Methods:
- Isolation of microRNAs from cell lines.
- Global microRNA profiling using advanced techniques.
- Investigation of microRNA expression in clinical specimens.
- In vitro assessment of therapeutic relevance via miRNA restoration using Lipofectamine.
Main Results:
- Identification of specific microRNAs with biomarker potential from cell line and clinical data.
- Demonstration of successful miRNA restoration in vitro.
- Validation of the developed approach for discovering novel miRNA biomarkers and therapeutics.
Conclusions:
- The presented methodology enables the discovery of microRNAs with significant biomarker and therapeutic potential.
- Circulating microRNAs hold promise for minimally invasive diagnostics and novel therapeutic strategies.
- Further investigation into miRNA restoration is warranted for clinical applications in disease treatment.
Related Concept Videos
DNA Microarrays
21.8K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.8K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K

